Solid Tumour clinical trials

Explore recruiting solid tumour clinical trials.

Recruiting solid tumour studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Tumour trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immunological variables associated to ICI toxicity in cancer patients

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, phase I/II first-in-human, dose escalation and confirmation study to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic and anti-tumour activity of IPN01195 as single agent in adult participants with advanced solid tumours

Spain, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors

Germany, France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Study of Personalized Neoantigen Specific TCR T cells in the Treatment of Advanced Solid Cancers

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralasertib with these medications in adults with advanced solid tumors

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Solid Tumour trials by city

Solid Tumour in Toronto Solid Tumour in Vancouver Solid Tumour in Montreal Solid Tumour in Calgary Solid Tumour in Edmonton Solid Tumour in Ottawa Solid Tumour in Winnipeg Solid Tumour in Quebec City Solid Tumour in Hamilton Solid Tumour in Kitchener Solid Tumour in London Solid Tumour in Halifax Solid Tumour in New York Solid Tumour in Los Angeles Solid Tumour in Chicago Solid Tumour in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease